Agreed. If the trial fails, the stock is not going to

Agreed. If the trial fails, the stock is not going to collapse because P is not the only drug in the pipeline. If it succeeds, icing on the cake.

Quote:

More importantly it has never been factored in to the share price so its like a bonus of sorts.